EXHIBIT 99.1

                                                           FOR IMMEDIATE RELEASE

    VALLEY FORGE SCIENTIFIC PAYS TRIBUTE TO LATE DIRECTOR DR. LEONARD MALIS

King of Prussia, Pa., September 14, 2005 -- Valley Forge Scientific Corp.
(NASDAQ: VLFG; BSE: VLF), with a profound sense of sorrow, announces the passing
of friend and director Dr. Leonard Malis on September 12, 2005. Leonard, who was
86, was Emeritus Chairman of the Department of Neurosurgery at Mount Sinai
Hospital in New York and a world renowned neurosurgeon. For personal reasons, he
had earlier in the year decided not to stand for reelection as a director of
Valley Forge at the company's Annual Meeting of Shareholders.

As one of the company's directors, Leonard shared a vision to expand Valley
Forge's business through the merger with Synergetics, Inc., which will occur
after approval at the shareholders' meetings for both companies being held over
the next four days.

About Valley Forge Scientific

Valley Forge is a medical device company that develops, manufactures and sells
medical devices for use in surgery and other healthcare applications. Its core
business involves the sale of bipolar electrosurgical generators and other
generators, based on its DualWaveTM technology, and complementary
instrumentation and disposable products. Their current line of products is used
in neurosurgery, spine surgery, pain control and in dental applications.

Forward-Looking Statements

Some statements in this announcement may be "forward-looking statements" for the
purposes of the Private Securities Litigation Reform Act of 1995. In some cases,
forward-looking statements can be identified by words such as "believe,"
"expect," "anticipate," "plan," "potential," "continue" or similar expressions.
Such forward-looking statements are based upon current expectations and beliefs
and are subject to a number of factors. These forward-looking statements are
subject to risks and uncertainties that may cause actual results to differ
materially from those indicated in the forward-looking statements, including but
not limited to: competitive, regulatory and market conditions; the performance
of new products and the continued acceptance of current products in the
marketplace; the execution of strategic initiatives and alliances; disruptions
caused by Valley Forge moving its assembly and manufacturing facility; the
market penetration by third parties who distribute and sell Valley Forge's
products; Valley Forge's ability to maintain a sufficient supply of products;
product liability claims; the uncertainties associated with intellectual
property protection for these products; the possibility that the merger
transaction with Synergetics will not close or that the closing will be delayed
due to the regulatory review or other factors; the challenges and costs of
combining the operations and personnel of Synergetics with Valley Forge; the
ability to attract and retain highly qualified employees; competitive factors,
including pricing pressures; reactions of customers of Valley Forge and
Synergetics and end-users of their products and related risks of maintaining
pre-existing relationships of Valley Forge and Synergetics; fluctuating current
exchange rates; adverse changes in general economic or market conditions; other
one-time events; and other important factors disclosed previously and from time
to time in Valley Forge's filings with the SEC and in the Joint Proxy
Statement/Prospectus filed by Valley Forge and Synergetics with the SEC.
Therefore, the reader is cautioned not to rely on these forward-looking
statements. Valley Forge disclaims any intent or obligation to update these
forward-looking statements.

                                       5